{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:35:35Z","timestamp":1787783735436,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shandong Provincial Key R & D programs","award":["2017GSF18174"],"award-info":[{"award-number":["2017GSF18174"]}]},{"name":"Science and Technology Projects in Qingdao West Coast New District","award":["2021-3"],"award-info":[{"award-number":["2021-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04044-w","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T10:29:42Z","timestamp":1752316182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A high proportion of CD38 (high) CD16 (low) NK cells in colorectal cancer can interrupt immune surveillance and favor tumor growth"],"prefix":"10.1007","volume":"74","author":[{"given":"Xueling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"4044_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2019.06.001","volume":"459","author":"A Bahrami","year":"2019","unstructured":"Bahrami A, Fereidouni M, Pirro M, Bianconi V, Sahebkar A (2019) Modulation of regulatory T cells by natural products in cancer. Cancer Lett 459:72\u201385. https:\/\/doi.org\/10.1016\/j.canlet.2019.06.001","journal-title":"Cancer Lett"},{"issue":"8","key":"4044_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/eji.202149358","volume":"52","author":"K Itahashi","year":"2022","unstructured":"Itahashi K, Irie T, Nishikawa H (2022) Regulatory T-cell development in the tumor microenvironment. Eur J Immunol 52(8):1216\u20131227. https:\/\/doi.org\/10.1002\/eji.202149358","journal-title":"Eur J Immunol"},{"key":"4044_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.crimmu.2021.08.002","volume":"2","author":"T Sarkar","year":"2021","unstructured":"Sarkar T, Dhar S, Sa G (2021) Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. Curr Res Immunol 2:132\u2013141. https:\/\/doi.org\/10.1016\/j.crimmu.2021.08.002","journal-title":"Curr Res Immunol"},{"key":"4044_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669474","volume":"12","author":"A Basu","year":"2021","unstructured":"Basu A, Ramamoorthi G, Albert G, Gallen C, Beyer A, Snyder C, Koski G, Disis ML, Czerniecki BJ, Kodumudi K (2021) Differentiation and regulation of TH cells: a balancing act for cancer immunotherapy. Front Immunol 12:669474. https:\/\/doi.org\/10.3389\/fimmu.2021.669474","journal-title":"Front Immunol"},{"issue":"1","key":"4044_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08923973.2019.1566925","volume":"41","author":"S Najafi","year":"2019","unstructured":"Najafi S, Mirshafiey A (2019) The role of T helper 17 and regulatory T cells in tumor microenvironment. Immunopharmacol Immunotoxicol 41(1):16\u201324. https:\/\/doi.org\/10.1080\/08923973.2019.1566925","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"23","key":"4044_CR6","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.3390\/cancers13236132","volume":"13","author":"K Matsuo","year":"2021","unstructured":"Matsuo K, Yoshie O, Nakayama T (2021) Multifaceted roles of chemokines and chemokine receptors in tumor immunity. Cancers (Basel) 13(23):6132. https:\/\/doi.org\/10.3390\/cancers13236132","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4044_CR7","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","volume":"86","author":"M de Weers","year":"2011","unstructured":"de Weers M, Tai YT, van der Veer MS, Bakker JM, Vink T, Jacobs DC, Oomen LA, Peipp M, Valerius T, Slootstra JW, Mutis T, Bleeker WK, Anderson KC, Lokhorst HM, van de Winkel JG, Parren PW (2011) Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol 86(3):1840\u20131848. https:\/\/doi.org\/10.4049\/jimmunol.1003032","journal-title":"J Immunol"},{"issue":"19","key":"4044_CR8","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-14-3639","volume":"75","author":"TA Karakasheva","year":"2015","unstructured":"Karakasheva TA, Waldron TJ, Eruslanov E, Kim S, Lee J, O\u2019Brien S, Hicks PD, Basu D, Singha S, Malavasi F, Rustgi AK (2015) CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer. Cancer Res 75(19):4074\u20134085. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3639","journal-title":"Cancer Res"},{"issue":"6","key":"4044_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97022","volume":"3","author":"TA Karakasheva","year":"2018","unstructured":"Karakasheva TA, Dominguez GA, Hashimoto A, Lin EW, Chiu C, Sasser K, Lee J, Beatty GL, Gabrilovich DI, Rustgi AK (2018) CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 3(6):e97022. https:\/\/doi.org\/10.1172\/jci.insight.97022","journal-title":"JCI Insight"},{"key":"4044_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos121","author":"A Levy","year":"2012","unstructured":"Levy A, Blacher E, Vaknine H, Lund FE, Stein R, Mayo L (2012) CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia\/macrophages. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/nos121","journal-title":"Neuro Oncol"},{"issue":"4","key":"4044_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41416-022-02052-6","volume":"128","author":"L Gao","year":"2023","unstructured":"Gao L, Du X, Li J, Qin FX (2023) Evolving roles of CD38 metabolism in solid tumour microenvironment. Br J Cancer 128(4):492\u2013504. https:\/\/doi.org\/10.1038\/s41416-022-02052-6","journal-title":"Br J Cancer"},{"issue":"1","key":"4044_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12935-022-02664-1","volume":"22","author":"Q Xu","year":"2022","unstructured":"Xu Q, Liu X, Mohseni G, Hao X, Ren Y, Xu Y, Gao H, Wang Q, Wang Y (2022) Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment. Cancer Cell Int 22(1):242. https:\/\/doi.org\/10.1186\/s12935-022-02664-1","journal-title":"Cancer Cell Int"},{"key":"4044_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12979-018-0115-x","volume":"15","author":"L Kaszubowska","year":"2018","unstructured":"Kaszubowska L, Foerster J, Kaczor JJ, Schetz D, \u015alebioda TJ, Kmie\u0107 Z (2018) NK cells of the oldest seniors represent constant and resistant to stimulation high expression of cellular protective proteins SIRT1 and HSP70. Immun Ageing 15:12. https:\/\/doi.org\/10.1186\/s12979-018-0115-x","journal-title":"Immun Ageing"},{"issue":"7534","key":"4044_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517(7534):293\u2013301. https:\/\/doi.org\/10.1038\/nature14189","journal-title":"Nature"},{"issue":"7","key":"4044_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3448","volume":"17","author":"S Cording","year":"2016","unstructured":"Cording S, Medvedovic J, Aychek T, Eberl G (2016) Innate lymphoid cells in defense, immunopathology and immunotherapy. Nat Immunol 17(7):755\u2013757. https:\/\/doi.org\/10.1038\/ni.3448","journal-title":"Nat Immunol"},{"issue":"3","key":"4044_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000325265","volume":"3","author":"YT Bryceson","year":"2011","unstructured":"Bryceson YT, Chiang SC, Darmanin S (2011) Molecular mechanisms of natural killer cell activation. J Innate Immun 3(3):216\u2013226. https:\/\/doi.org\/10.1159\/000325265","journal-title":"J Innate Immun"},{"issue":"4","key":"4044_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM (2013) The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 12(4):1069\u20131078. https:\/\/doi.org\/10.1016\/j.arr.2013.04.003","journal-title":"Ageing Res Rev"},{"issue":"5","key":"4044_CR18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.7150\/ijbs.68148","volume":"18","author":"H Wu","year":"2022","unstructured":"Wu H, Zhao X (2022) Regulation of CD38 on multiple myeloma and NK cells by monoclonal antibodies. Int J Biol Sci 18(5):1974\u20131988. https:\/\/doi.org\/10.7150\/ijbs.68148","journal-title":"Int J Biol Sci"},{"key":"4044_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645478","volume":"12","author":"M Humbel","year":"2021","unstructured":"Humbel M, Bellanger F, Fluder N, Horisberger A, Suffiotti M, Fenwick C, Ribi C, Comte D (2021) Restoration of NK cell cytotoxic function with elotuzumab and daratumumab promotes elimination of circulating plasma cells in patients with SLE. Front Immunol 12:645478. https:\/\/doi.org\/10.3389\/fimmu.2021.645478","journal-title":"Front Immunol"},{"issue":"5","key":"4044_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep4.1332","volume":"3","author":"S Kim","year":"2019","unstructured":"Kim S, Moore J, Alonso E, Bednarek J, Bezerra JA, Goodhue C, Karpen SJ, Loomes KM, Magee JC, Ng VL, Sherker AH, Smith C, Spino C, Venkat V, Wang K, Sokol RJ, Mack CL (2019) Correlation of immune markers with outcomes in biliary atresia following intravenous immunoglobulin therapy. Hepatol Commun 3(5):685\u2013696. https:\/\/doi.org\/10.1002\/hep4.1332","journal-title":"Hepatol Commun"},{"issue":"1","key":"4044_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41598-017-00637-3","volume":"7","author":"JF Lima","year":"2017","unstructured":"Lima JF, Oliveira LMS, Pereira NZ, Duarte AJS, Sato MN (2017) Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects. Sci Rep 7(1):524. https:\/\/doi.org\/10.1038\/s41598-017-00637-3","journal-title":"Sci Rep"},{"issue":"6","key":"4044_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4049\/jimmunol.2200422","volume":"210","author":"M Wang","year":"2023","unstructured":"Wang M, Chen W, Zhang X, Mei L, Wu X, Chen X, Yang Z, Gao K, Huang H, Huang R (2023) Single-cell analysis in blood reveals distinct immune cell profiles in gouty arthritis. J Immunol 210(6):745\u2013752. https:\/\/doi.org\/10.4049\/jimmunol.2200422","journal-title":"J Immunol"},{"issue":"2","key":"4044_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000516642","volume":"14","author":"H Wang","year":"2022","unstructured":"Wang H, Fang K, Yan W, Chang X (2022) T-cell immune imbalance in rheumatoid arthritis is associated with alterations in NK cells and NK-like T cells expressing CD38. J Innate Immun 14(2):148\u2013166. https:\/\/doi.org\/10.1159\/000516642","journal-title":"J Innate Immun"},{"issue":"1","key":"4044_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-019-2001-0","volume":"21","author":"H Wang","year":"2019","unstructured":"Wang H, Li S, Zhang G, Wu H, Chang X (2019) Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation. Arthritis Res Ther 21(1):220. https:\/\/doi.org\/10.1186\/s13075-019-2001-0","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4044_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.55563\/clinexprheumatol\/0dck3t","volume":"41","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang H, Song X, Song Y, He G, Fang K, Chang X (2023) Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis. Clin Exp Rheumatol 41(7):1384\u20131395. https:\/\/doi.org\/10.55563\/clinexprheumatol\/0dck3t","journal-title":"Clin Exp Rheumatol"},{"issue":"23","key":"4044_CR26","doi-asserted-by":"publisher","first-page":"9730","DOI":"10.18632\/aging.204425","volume":"14","author":"H Zhou","year":"2022","unstructured":"Zhou H, Liu S, Zhang N, Fang K, Zong J, An Y, Chang X (2022) Downregulation of Sirt6 by CD38 promotes cell senescence and aging. Aging (Albany NY) 14(23):9730\u20139757. https:\/\/doi.org\/10.18632\/aging.204425","journal-title":"Aging (Albany NY)"},{"key":"4044_CR27","doi-asserted-by":"publisher","first-page":"1309785","DOI":"10.3389\/fonc.2024.1309785","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Li H, Chen H, Fang K, Chang X (2024) Overexpression of circulating CD38+ NK cells in colorectal cancer was associated with lymph node metastasis and poor prognosis. Front Oncol 14:1309785. https:\/\/doi.org\/10.3389\/fonc.2024.1309785","journal-title":"Front Oncol"},{"issue":"1","key":"4044_CR28","doi-asserted-by":"publisher","first-page":"28702","DOI":"10.1038\/s41598-024-79008-8","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, Song X, Fang K, Chang X (2024) CD38 modulates cytokine secretion by NK cells through the Sirt1\/NF-\u03baB pathway, suppressing immunesurveillance in colorectal cancer. Sci Rep 14(1):28702. https:\/\/doi.org\/10.1038\/s41598-024-79008-8","journal-title":"Sci Rep"},{"issue":"7","key":"4044_CR29","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1182\/blood.v99.7.2490","volume":"99","author":"S Deaglio","year":"2002","unstructured":"Deaglio S, Zubiaur M, Gregorini A, Bottarel F, Ausiello CM, Dianzani U, Sancho J, Malavasi F (2002) Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 99(7):2490\u20132498. https:\/\/doi.org\/10.1182\/blood.v99.7.2490","journal-title":"Blood"},{"issue":"6","key":"4044_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00262-018-2140-1","volume":"67","author":"NM Mahaweni","year":"2018","unstructured":"Mahaweni NM, Bos GMJ, Mitsiades CS, Tilanus MGJ, Wieten L (2018) Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions. Cancer Immunol Immunother 67(6):861\u2013872. https:\/\/doi.org\/10.1007\/s00262-018-2140-1","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"4044_CR31","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1158\/1078-0432.ccr-20-3418","volume":"27","author":"H Cho","year":"2021","unstructured":"Cho H, Kim KH, Lee H, Kim CG, Chung H, Choi YS, Park SH, Cheong JW, Min YH, Shin EC, Kim JS (2021) Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma. Clin Cancer Res 27(10):2947\u20132958. https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-3418","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4044_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","volume":"33","author":"H Lv","year":"2021","unstructured":"Lv H, Lv G, Chen C, Zong Q, Jiang G, Ye D, Cui X, He Y, Xiang W, Han Q, TangL YW, Wang H (2021) NAD+ metabolism maintains inducible PD-L1 expression to drive tumor immune evasion. Cell Metab 33(1):110-127.e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.021","journal-title":"Cell Metab"},{"issue":"3","key":"4044_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.chembiol.2017.12.008","volume":"25","author":"W Wang","year":"2018","unstructured":"Wang W, Hu Y, Wang X, Wang Q, Deng H (2018) ROS-mediated15-hydroxyprostaglandin dehydrogenase degradation via cysteine oxidation promotes NAD+-mediated epithelial-mesenchymal transition. Cell Chem Biol 25(3):255-261.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2017.12.008","journal-title":"Cell Chem Biol"},{"key":"4044_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850856","volume":"13","author":"S Pernot","year":"2022","unstructured":"Pernot S, Evrard S, Khatib AM (2022) The give-and-take interaction betweenthe tumor microenvironment and immune cells regulating tumor progression. Front Immunol 13:850856. https:\/\/doi.org\/10.3389\/fimmu.2022.850856","journal-title":"Front Immunol"},{"issue":"3","key":"4044_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12032-024-02300-0","volume":"41","author":"K Mortezaee","year":"2024","unstructured":"Mortezaee K (2024) Selective targeting or reprogramming of intra-tumoral Tregs. Med Oncol 41(3):71. https:\/\/doi.org\/10.1007\/s12032-024-02300-0","journal-title":"Med Oncol"},{"key":"4044_CR36","doi-asserted-by":"publisher","first-page":"1192303","DOI":"10.3389\/fimmu.2023.1192303","volume":"14","author":"Y Pan","year":"2023","unstructured":"Pan Y, Yang W, Tang B, Wang X, Zhang Q, Li W, Li L (2023) The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment. Front Immunol 14:1192303. https:\/\/doi.org\/10.3389\/fimmu.2023.1192303","journal-title":"Front Immunol"},{"issue":"12","key":"4044_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029041","volume":"8","author":"A Kitz","year":"2018","unstructured":"Kitz A, Singer E, Hafler D (2018) Regulatory T cells: from discovery to autoimmunity. Cold Spring Harb Perspect Med 8(12):a029041. https:\/\/doi.org\/10.1101\/cshperspect.a029041","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4044_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-319-15774-0_2","volume":"850","author":"S Piconese","year":"2015","unstructured":"Piconese S, Barnaba V (2015) Stability of regulatory T cells undermined orendorsed by different type-1 cytokines. Adv Exp Med Biol 850:17\u201330. https:\/\/doi.org\/10.1007\/978-3-319-15774-0_2","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4044_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/eji.202048746","volume":"51","author":"CM Wardell","year":"2021","unstructured":"Wardell CM, MacDonald KN, Levings MK, Cook L (2021) Cross talk between human regulatory T cells and antigen-presenting cells: lessons for clinical applications. Eur J Immunol 51(1):27\u201338. https:\/\/doi.org\/10.1002\/eji.202048746","journal-title":"Eur J Immunol"},{"issue":"10","key":"4044_CR40","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013) Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 25(10):1939\u20131948. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.007","journal-title":"Cell Signal"},{"issue":"12","key":"4044_CR41","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 23(12):2369\u20132380. https:\/\/doi.org\/10.1038\/sj.emboj.7600244","journal-title":"Embo J"},{"key":"4044_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8736949","author":"Y Qian","year":"2018","unstructured":"Qian Y, Chen C, Ma L, Wang Z, Wang LF, Zuo L, Yang Y, Huang X, Jiang M, Wang X, Shi H, Fu M, Deng KY, Xin HB (2018) CD38 deficiency promotes inflammatory response through activating Sirt1\/NF-\u03baB-mediated inhibition of TLR2 expression in macrophages. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2018\/8736949","journal-title":"Mediators Inflamm"},{"issue":"4","key":"4044_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13577-015-0118-2","volume":"28","author":"N Zulaziz","year":"2015","unstructured":"Zulaziz N, Azhim A, Himeno N, Tanaka M, Satoh Y, Kinoshita M, Miyazaki H, Saitoh D, Shinomiya N, Morimoto Y (2015) Photodynamic therapy mediates innate immune responses via fibroblast-macrophage interactions. Hum Cell 28(4):159\u2013166. https:\/\/doi.org\/10.1007\/s13577-015-0118-2","journal-title":"Hum Cell"},{"issue":"11","key":"4044_CR44","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/s0301-472x(99)00104-6","volume":"27","author":"G Multhoff","year":"1999","unstructured":"Multhoff G, Mizzen L, Winchester CC, Milner CM, Wenk S, Eissner G, Kampinga HH, Laumbacher B, Johnson J (1999) Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol 27(11):1627\u20131636. https:\/\/doi.org\/10.1016\/s0301-472x(99)00104-6","journal-title":"Exp Hematol"},{"key":"4044_CR45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12885-016-2592-7","volume":"16","author":"N Jagadish","year":"2016","unstructured":"Jagadish N, Parashar D, Gupta N, Agarwal S, Suri V, Kumar R, Suri V, Sadasukhi TC, Gupta A, Ansari AS, Lohiya NK, Suri A (2016) Heat shock protein 70\u20132 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth. BMC Cancer 16:561. https:\/\/doi.org\/10.1186\/s12885-016-2592-7","journal-title":"BMC Cancer"},{"key":"4044_CR46","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2147\/jir.s352717","volume":"15","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Song C, Ni W, Pei Q, Wang C, Ying Y, Yao M (2022) HSP70 ameliorates septic acute kidney injury via binding with TRAF6 to Inhibit of inflammation-mediated apoptosis. J Inflamm Res 15:2213\u20132228. https:\/\/doi.org\/10.2147\/jir.s352717","journal-title":"J Inflamm Res"},{"issue":"6","key":"4044_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.18502\/ijaai.v18i6.2172","volume":"18","author":"MA Vostakolaei","year":"2019","unstructured":"Vostakolaei MA, Abdolalizadeh J, Hejazi MS, Kordi S, Molavi O (2019) Hsp70 in cancer: partner or traitor to immune system. Iran J Allergy Asthma Immunol 18(6):589\u2013604. https:\/\/doi.org\/10.18502\/ijaai.v18i6.2172","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"4044_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.trim.2004.08.003","volume":"13","author":"KH Oh","year":"2004","unstructured":"Oh KH, Kim JY, Kim D, Lee EM, Oh HY, Seo JS, Han JS, Kim S, Lee JS, Ahn C (2004) Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model. Transpl Immunol 13(4):273\u2013281. https:\/\/doi.org\/10.1016\/j.trim.2004.08.003","journal-title":"Transpl Immunol"},{"issue":"3","key":"4044_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.shk.0000223134.17877.ad","volume":"26","author":"Y Shi","year":"2006","unstructured":"Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang K, Calderwood SK, Xiao X (2006) The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 26(3):277\u2013284. https:\/\/doi.org\/10.1097\/01.shk.0000223134.17877.ad","journal-title":"Shock"},{"issue":"5","key":"4044_CR50","doi-asserted-by":"publisher","first-page":"L956","DOI":"10.1152\/ajplung.00466.2005","volume":"290","author":"KD Singleton","year":"2006","unstructured":"Singleton KD, Wischmeyer PE (2006) Effects of HSP70.1\/3 gene knockout on acute respiratory distress syndrome and the inflammatory response following sepsis. Am J Physiol Lung Cell Mol Physiol 290(5):L956-961. https:\/\/doi.org\/10.1152\/ajplung.00466.2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4044_CR51","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4044_CR52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cncr.23239","volume":"112","author":"P Carrega","year":"2008","unstructured":"Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, Ratto GB, Mingari MC, Moretta L, Ferlazzo G (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 112(4):863\u2013875. https:\/\/doi.org\/10.1002\/cncr.23239","journal-title":"Cancer"},{"issue":"12","key":"4044_CR53","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1089\/thy.2012.0560","volume":"23","author":"F Gogali","year":"2013","unstructured":"Gogali F, Paterakis G, Rassidakis GZ, Liakou CI, Liapi C (2013) CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer. Thyroid 23(12):1561\u20131568. https:\/\/doi.org\/10.1089\/thy.2012.0560","journal-title":"Thyroid"},{"issue":"11","key":"4044_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078049","volume":"8","author":"KC Koo","year":"2013","unstructured":"Koo KC, Shim DH, Yang CM, Lee SB, Kim SM, Shin TY, Kim KH, Yoon HG, Rha KH, Lee JM, Hong SJ (2013) Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer. PLoS ONE 8(11):e78049. https:\/\/doi.org\/10.1371\/journal.pone.0078049","journal-title":"PLoS ONE"},{"issue":"12","key":"4044_CR55","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00262-010-0897-y","volume":"59","author":"TL Frankel","year":"2010","unstructured":"Frankel TL, Burns W, Riley J, Morgan RA, Davis JL, Hanada K, Quezado M, Rosenberg SA, Royal RE (2010) Identification and characterization of a tumor infiltrating CD56(+)\/CD16 (-) NK cell subset with specificity for pancreatic and prostate cancer cell lines. Cancer Immunol Immunother 59(12):1757\u20131769. https:\/\/doi.org\/10.1007\/s00262-010-0897-y","journal-title":"Cancer Immunol Immunother"},{"key":"4044_CR56","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2016.00492","volume":"7","author":"M Shevtsov","year":"2016","unstructured":"Shevtsov M, Multhoff G (2016) Immunological and translational aspects of NK cell-based antitumor immunotherapies. Front Immunol 7:492. https:\/\/doi.org\/10.3389\/fimmu.2016.00492","journal-title":"Front Immunol"},{"key":"4044_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fimmu.2016.00351","volume":"7","author":"M Della Chiesa","year":"2016","unstructured":"Della Chiesa M, Pesce S, Muccio L, Carlomagno S, Sivori S, Moretta A, Marcenaro E (2016) Features of memory-like and PD-1(+) Human NK cell subsets. Front Immunol 7:351. https:\/\/doi.org\/10.3389\/fimmu.2016.00351","journal-title":"Front Immunol"},{"issue":"7","key":"4044_CR58","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, Zimmer J (2016) Human CD56bright NK cells: an update. J Immunol 196(7):2923\u20132931. https:\/\/doi.org\/10.4049\/jimmunol.1502570","journal-title":"J Immunol"},{"key":"4044_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/82_2010_20","volume":"341","author":"AA Maghazachi","year":"2010","unstructured":"Maghazachi AA (2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341:37\u201358. https:\/\/doi.org\/10.1007\/82_2010_20","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"4044_CR60","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J (2009) CD56bright natural killer (NK) cells: an important NK cell subset. J Immunology 126(4):458\u2013465. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x","journal-title":"J Immunology"},{"issue":"3","key":"4044_CR61","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4049\/jimmunol.1500591","volume":"195","author":"F Morandi","year":"2015","unstructured":"Morandi F, Horenstein AL, Chillemi A, Quarona V, Chiesa S, Imperatori A, Zanellato S, Mortara L, Gattorno M, Pistoia V, Malavasi F (2015) CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation. J Immunol 195(3):965\u2013972. https:\/\/doi.org\/10.4049\/jimmunol.1500591","journal-title":"J Immunol"},{"issue":"1","key":"4044_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12865-019-0293-0","volume":"20","author":"C Balinas","year":"2019","unstructured":"Balinas C, Cabanas H, Staines D, Marshall-Gradisnik S (2019) Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry. BMC Immunol 20(1):14. https:\/\/doi.org\/10.1186\/s12865-019-0293-0","journal-title":"BMC Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04044-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04044-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:02:53Z","timestamp":1754330573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04044-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4044"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04044-w","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest associated with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental design was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (QYFYWZLL27438).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This manuscript does not contain patient personal data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"263"}}